Pressure-support versus T-piece breathing test for overweight and obese adults on ventilators
Official title: Comparison of Pressure Support Ventilation and T-Piece as Spontaneous Breathing Trials Before Extubation Among Obese and Overweight Patients
Run by Taipei Medical University Hospital · NCT07114289 · Data updated 2026-11-12
This test will see if a one-hour pressure-support or T-piece breathing trial helps overweight and obese adults on a ventilator be successfully extubated without needing reintubation within 72 hours.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Taipei Medical University Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | September 29, 2025 |
| Main results expected | March 31, 2027 |
| Study ends | July 31, 2027 |
| Registry record updated | November 17, 2025 |
| Trial ID | NCT07114289 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age ≥18) with BMI ≥25 who have been invasively ventilated for over 24 hours and meet international weaning criteria, with informed consent, are the ideal candidates.
✕Probably not a fit
Patients with tracheostomy, unstable vital signs, ongoing deep sedation, recent major trauma, or who do not meet weaning criteria are unlikely to benefit or are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized study enrolls adults with BMI ≥25 who have been invasively mechanically ventilated for more than 24 hours and meet standard weaning criteria. Participants are randomly assigned to a one-hour spontaneous breathing trial using either pressure support ventilation (PSV) or a T-piece, after which treating clinicians decide on extubation. The primary outcome is successful extubation, defined as not requiring reintubation within 72 hours. Secondary data collected include respiratory parameters, need for ventilatory support after extubation, and ICU length of stay.
Why it matters
Potential benefit: If successful, this could increase first-attempt extubation rates for overweight and obese patients and reduce time on mechanical ventilation and related complications.
How similar studies have gone: Previous randomized comparisons of PSV and T-piece in general ICU populations have produced mixed results—some favor PSV for comfort or easier weaning, while others show no clear difference—so applying this comparison specifically to overweight and obese patients is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1\. Patients had undergone intubation and mechanical ventilation for more than 24 hours prior to the first spontaneous breathing trial. 2\. Adult patients aged ≥ 18 years. 3. BMI ≥ 25 kg/m². 4. Meeting all the Inter national Consensus Conference on weaning criteria: 1. Stable vital signs: heart rate \< 140 beats/min, systolic blood pressure: 90-160 mmHg, and no use of vasopressors or use of minimal doses (\<0.2 µg/kg per min). 2. Respiratory rate ≤ 35 breaths/min. 3. Adequate oxygenation, defined as either SpO2 \> 90% with FiO2 ≤ 0.4, or PaO2/FiO2 \> 150 mmHg with positive end-expiratory pressure (PEEP) ≤ 8 cmH2O. 4. Adequate cough strength (MIP \< -20 cmH2O). 5. An awake state, defined as a score of Richmond Agitation-Sedation Scale between +1 and -2, or Glasgow Coma Scale \> 8. 6. No continuous sedation. 5. Informed consent provided by the patient or their relatives. Exclusion Criteria: 1. Patients with tracheostomy. 2. Patients who had been admitted for traumatic brain injury. 3. Patients who had preexisting peripheral neuromuscular disease (underlying myopathy or myasthenia gravis). 4. Patients who had a do-not-reintubate order at the time of the initial spontaneous breathing trial were excluded 5. Patients who have already undergone a first spontaneous breathing trial. 6. Patients who had undergone extubation without an SBT 7. Protected populations: pregnant or breastfeeding women, individuals under guardianship, or those under legal protection. 8. Patients who refused to participate during the study.
Where it's running
-
Taipei Medical University Hospital
Taipei, Taiwan Recruiting
Study contacts
- Study coordinator: Respiratory therapist
- Email: lynnho0326@gmail.com
- Phone: +886-937870463
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PEEP levels and breathing effort during assisted mechanical ventilation
This trial tests whether changing PEEP levels can reduce excessive breathing effort in adults receiving assisted mechanical ventilation in the ICU.
-
Supervised exercise after bariatric surgery to protect muscle and bone
This program tests whether supervised exercise after gastric bypass or sleeve surgery helps preserve muscle mass and bone density in adults.
-
Comparing a standard versus an intensified interactive Get Ready app to support patients having bariatric surgery
This trial tests whether an intensified, interactive version of the Get Ready smartphone app helps people having bariatric surgery follow their pre- and post‑operative plan better than the standard app.
-
Phase 1/2a: RN3161 alone and with tirzepatide for safety, how the drug works in the body, and effects on weight in adults with overweight or obesity
This trial will test RN3161 by itself in healthy volunteers and RN3161 with tirzepatide in adults with overweight or obesity to see if it is safe and changes body weight.
-
Grape powder effects on gut and immune health in adults with obesity
This 12-week test will see if taking 48 g per day of freeze-dried grape powder changes the gut microbiome and immune markers in adults aged 30–45 with obesity.
-
Probiotic Support for GLP-1 RA Weight Loss in Obesity
This study tests whether adding probiotics helps people starting GLP-1 receptor agonist treatment for obesity see if they tolerate the medication better and possibly lose more weight.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.